Abstract

BackgroundFlow diverters (FDs) are widely used in the treatment of intracranial aneurysms, but the required medication increases the risk of haemorrhagic complications and limits their use in the acute setting. Surface modified FDs may limit the need for dual antiplatelet therapy (DAPT). Hydrophilic polymer coating (HPC) may reduce the need of medication.MethodsThis explorative study, approved by the local authorities and the local welfare committee, compared stent behaviour and overall tissue response between HPC-coated FDs and uncoated FDs, both implanted into the common carotid arteries of eight New Zealand white rabbits. Endothelialisation, inflammatory response, and performance during implantation were assessed. Angiographic follow-up was performed to observe the patency of the devices after implantation and after 30 days. Histological examinations were performed at 30 days to assess foreign body reaction and endothelialisation. Kruskal-Wallis and Wilcoxon tests were used to compare non-parametric variables.ResultsAngiography showed that both coated and uncoated FDs performed well during implantation. All devices remained patent during immediate follow-up and after 30 days. Histopathology showed no significant difference in inflammation within the vessel wall between the two cohorts (2.12 ± 0.75 vs. 1.96 ± 0.79, p = 0.7072). Complete endothelialisation of the stent struts was seen with very similar (0.04 ± 0.02 mm vs. 0.04 ± 0.03 mm, p = 0.892) neoendothelial thickness between the two cohorts after 30 days.ConclusionTaking into account the limitation in sample size, non-significant differences between the HPC-coated and uncoated FDs regarding implantation, foreign body response, and endothelialisation were found.

Highlights

  • Flow diverters (FDs) are widely used in the treatment of intracranial aneurysms, but the required medication increases the risk of haemorrhagic complications and limits their use in the acute setting

  • The introduction of flow diverter (FD) stents allowed the treatment of aneurysms that were previously difficult to treat or untreatable

  • One of the principle concerns when using endovascular stents and FDs is the need for dual antiplatelet therapy (DAPT)

Read more

Summary

Introduction

Flow diverters (FDs) are widely used in the treatment of intracranial aneurysms, but the required medication increases the risk of haemorrhagic complications and limits their use in the acute setting. One of the principle concerns when using endovascular stents and FDs is the need for dual antiplatelet therapy (DAPT). This is necessary in order to prevent thromboembolic complications. Ajadi et al [6] recently performed a meta-analysis on studies published between 2013 and 2018 to determine the predictive value of the preoperative platelet reactivity units (PRU) They identified 12 studies that met the study criteria including data from 1464 PED cases and demonstrated that preprocedural hypo-response, defined as a PRU ranging from > 200 to > 240, carried an increased risk of thrombotic events with an absolute risk of 15%. In addition to the problems of predictability in response to antiplatelet medications, drug interactions can interfere with the activity of these medications [7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call